Nadine Tung
- Genetics top 0.1%
- Oncology top 0.2%
- Molecular Biology top 2%
- Cancer Research top 0.2%
- Pulmonary and Respiratory Medicine top 1%
- Co-authors
- Judy E. GarberSusan M. DomchekMark E. RobsonSteven A. NarodAnne ArmstrongBinghe XuElżbieta SenkusPierfranco Conté
- Topics
- BRCA gene mutations in cancer (113 papers)PARP inhibition in cancer therapy (44 papers)Cancer Genomics and Diagnostics (40 papers)
- Cited by
- Cancer ResearchGeneticsOncology
- Partner nations
- United StatesCanadaPoland
In The Last Decade
Nadine Tung
183 papers receiving 11.0k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Genetics 5.9k
- Oncology 5.7k
- Molecular Biology 3.9k
- Cancer Research 3.8k
- Pulmonary and Respiratory Medicine 1.7k
Countries citing papers authored by Nadine Tung
This map shows the geographic impact of Nadine Tung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadine Tung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadine Tung more than expected).
Fields of papers citing papers by Nadine Tung
This network shows the impact of papers produced by Nadine Tung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadine Tung. The network helps show where Nadine Tung may publish in the future.
Co-authorship network of co-authors of Nadine Tung
This figure shows the co-authorship network connecting the top 25 collaborators of Nadine Tung. A scholar is included among the top collaborators of Nadine Tung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadine Tung. Nadine Tung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 16 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 8 | |
| 7 | 8 | |
| 8 | 54 | |
| 9 | 22 | |
| 10 | 7 | |
| 11 | 12 | |
| 12 | 14 | |
| 13 | 78 | |
| 14 | 23 | |
| 15 | Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutationbreakdown → | 2156 |
| 16 | 95 | |
| 17 | 412 | |
| 18 | 14 | |
| 19 | 9 | |
| 20 | 84 |
About Nadine Tung
Nadine Tung is a scholar working on Genetics, Cancer Research and Oncology, having authored 190 papers that have together received 11.3k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (113 papers), PARP inhibition in cancer therapy (44 papers) and Cancer Genomics and Diagnostics (40 papers). The work is most often cited by research in Cancer Research (3.8k citations), Genetics (5.9k citations) and Oncology (5.7k citations). Nadine Tung has collaborated with scholars based in United States, Canada and Poland. Frequent co-authors include Judy E. Garber, Susan M. Domchek, Mark E. Robson, Steven A. Narod, Anne Armstrong, Binghe Xu, Elżbieta Senkus, Pierfranco Conté, Norikazu Masuda and Seock‐Ah Im. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.